Interleukin-2 (Amgen)

N/A

Report date: 2022/08/22 20:00:20

Base Information

Drug NameInterleukin-2 (Amgen)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionInterleukin-2 receptor agonists

TargetsInterleukin-2 receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A